Install
Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to best-in-class tools. From in-depth anal
- 2,799articles · 30d
- 1+ hour agolatest article
- Aug 14, 2026earliest in window
- 95%with images
- 65avg words
- Economy, Business & Finance 2,435
- Finance & Business 2,305
- News 1,170
- Finance 880
- Business & Industrial 420
- Industrial 122
- Science & Technology 115
- Politics 93
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Kardigan: Funded Precision Cardiology Offers More Than Pipeline Diversification
9+ hour, 47+ min ago (89+ words) Seeking Alpha - Kardigan targets genetic DCM, moderate CAVS, and post-hospitalization ASH with differentiated, biology-driven clinical programs. - KARD holds $660.7M in liquid assets, providing roughly 2–3 years of runway to achieve key clinical readouts before further funding is needed. - Upcoming 2027 data from all…...
EverCommerce boosts share buyback plan by $25M, lifting total to $325M
1+ day, 22+ hour ago (13+ words) EverCommerce boosts share buyback to $325M through 2027, funded by cash on hand....
General Dynamics wins $184M Navy deal for NGEAU production
2+ day, 22+ hour ago (14+ words) General Dynamics wins $184.25M U.S. Navy contract for Next-Gen Electronics Attack Units through 2032....
enGene Therapeutics: Slashing Cash Burn To Bring Their Asset To The Market
3+ day, 7+ min ago (98+ words) Seeking Alpha - enGene Therapeutics remains deeply undervalued, trading below its $3.97/share cash position despite pipeline and execution risks. - ENGN’s lead asset, detalimogene voraplasmid, faces FDA approval risk due to weak 12-month durability, but management is pursuing a surfactant cohort to…...
Aquarian purchase of Brighthouse Financial delayed by regulators - report
3+ day ago (87+ words) Seeking Alpha Aquarian's $4.1 billion deal to purchase life insurer Brighthouse Financial (BHF) has been delayed as regulators investigate the deal. Delaware’s insurance regulator questioned Aquarian founder Rudy Sahay in a closed-door meeting recently about the firm’s sources of capital backing…...
Calamos Global Convertible Strategy Q2 2026 Commentary
3+ day, 6+ hour ago (9+ words) Seeking Alpha...
Tsakos Energy Navigation GAAP EPS of $4.40, revenue of $298.41M beats by $69.5M (TEN:NYSE)
3+ day, 6+ hour ago (15+ words) ...
LSL Pharma announces CFO transition (LSL:CA:TSXV)
3+ day, 8+ hour ago (17+ words) LSL Pharma Group announces CFO Luc Mainville’s immediate departure as the company begins a formal CFO search....
Using Benchmarks To Understand And Measure Digital Assets
3+ day, 10+ hour ago (79+ words) Seeking Alpha - In traditional asset classes, the relationship between a strategy and its benchmark is generally well understood. In digital assets, that relationship is still developing. - Bitcoin’s performance profile differs from other digital assets - such as ecosystem layers like Ethereum…...
Kioxia chief rules out deeper ties with rival SK Hynix - report (SKHY:NASDAQ)
4+ day, 4+ hour ago (59+ words) Seeking Alpha Moostocker/iStock via Getty Images Kioxia Holdings (KXIAY) (KXHCF) CEO Hiroo Ota has played down the prospect of deeper ties with South Korea’s SK Hynix (SKHY), citing antitrust concerns and the Japanese memory-chip maker’s existing manufacturing arrangements with…...